Donate to PAPAA
All this information is available to you FREE. If you found it useful please show your appreciation. Thank you.
Be part of the solution and make a difference
The PAPAA Forum: Coronavirus (COVID-19)
Sulfasalasine and Covid-19 infection
- Author: Dr David Ashton
- Topic: Coronavirus (COVID-19)
Sulfasalasine, a disease-modifying antirheumatic drug (DMARD), has a well-established role in the treatment of patients with chronic inflammatory diseases, such a rheumatoid arthritis, inflammatory bowel disease and psoriatic arthritis. It is often used in patients who are unable to tolerate methotrexate. Sulfasalasine has anti-inflammatory,…
Psoriasis patients more susceptible to COVID-19
- Author: Dr David Ashton
- Topic: Coronavirus (COVID-19)
As the COVID-19 pandemic has continued, researchers have been able to study individual groups of patients with pre-existing medical conditions – including psoriasis. One especially important question, is whether patients diagnosed with psoriasis, could be more at risk of infection with COVID-19?
In a recent (virtual) meeting of the American…
COVID-19 updated guidance on shielding
- Author: David Chandler
- Topic: Coronavirus (COVID-19)
Clinically extremely vulnerable groups
With the changing COVID-19 restrictions, you may like to know what the definition of clinically extremely vulnerable groups are
People who are defined as clinically extremely vulnerable are at very high risk of severe illness from coronavirus. There are 2 ways you may be identified as clinically extremely…
Coronavirus (COVID-19) statistics
- Author: David Chandler
- Topic: Coronavirus (COVID-19)
As the daily news appears to report the rise of positive cases and testing, you may like to read the official statistics from the Government website
The website includes the numbers of cases, deaths and tests. The site also includes graphs and cumulative data. There is also a breakdown for all four UK nations (England, Scotland, Wales and…